May 3, 2017 (Waterloo, ON) – Intellijoint Surgical® is pleased to welcome Dr. Michael Bradley, MD, MBA, MS, as the newest member to its Scientific Advisory Board (SAB). Dr. Bradley is Chief of Orthopaedics at South County Hospital in Wakefield, Rhode Island, and President/CEO of Ortho Rhode Island. As a board-certified surgeon, he brings 12 years of orthopaedic […]
Tuesday, April 11, 2017 (Waterloo, ON) – Intellijoint Surgical® is proud to announce that intellijoint HIP® has now – only one year after commercial launch – been used in over 1,000 total hip replacement procedures in the United States, Canada and Australia. intellijoint HIP® is a novel medical device providing 3D mini-optical navigation for orthopaedic surgeons. The one thousandth case
March 7, 2017 (Waterloo, Ontario) – Intellijoint Surgical® Inc., a privately-held Canadian medical technology company, announces FDA clearance of intellijoint HIP® Anterior, the newest application to the intellijoint HIP suite. intellijoint HIP Anterior is a 3D mini-optical navigation solution that provides quantifiable, intraoperative measurements for cup position, leg length, and offset to orthopaedic surgeons performing Direct Anterior Approach (DAA) Total Hip Arthroplasty (THA). “intellijoint HIP Anterior has been
Intellijoint Surgical® Announces intellijoint HIP® Anterior Application FDA Clearance Read More »
Intellijoint Surgical® was featured in the Record’s 2016 Technology Spotlight magazine alongside some of Kitchener-Waterloo’s best tech companies.
Intellijoint Surgical featured in 2016 Technology Spotlight Read More »
Intellijoint Surgical® chats with MedCity News about the recent 11M funding announcement and future growth.
MedCity News’ Feature on Intellijoint Surgical Read More »
From inception to commercialization in less than six years, Intellijoint Surgical® is excited to announce the completion of its Series A fundraising round – the biggest milestone to date. Read Full Press Release Press Release;
Intellijoint Surgical® Raises $11MM to Expand the US Launch of intellijoint HIP® Read More »
Intellijoint Surgical CEO, Armen Bakirtzian, discusses the challenges of securing funding as the company advances to the next stage of growth. Read Full Article
Globe and Mail: Leave Canada to succeed? Startup feels the pressure Read More »
July 8, 2016 (Waterloo, Ontario) – Intellijoint Surgical® – a privately held Canadian medical technology company committed to developing and commercializing affordable 3D mini-optical navigation tools – is pleased to announce the first successful clinical use of the Direct Anterior Approach (DAA) Application of intellijoint HIP®. DAA is a minimally invasive surgical technique that approaches Total Hip Arthroplasty (THA)
Waterloo, Ontario, March 17, 2016 – Intellijoint Surgical Inc., a privately held Canadian medical technology company committed to developing and commercializing miniaturized surgical smart tools announced today the signing of a distribution agreement with Corin Group. The deal gives Corin distribution rights for Intellijoint’s flagship product, intellijoint HIP™, in Australia and paves the way for broader distribution and
Intellijoint Surgical & Corin Group enter strategic partnership for intellijoint HIP™ Read More »
